[Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy].

Ginekol Pol

Zakładu Anestezjologii w Ginekologii i Połoznictwie Instytutu Anestezjologii i Intensywnej Terapii Akademii Medycznej w Poznaniu.

Published: March 2002

AI Article Synopsis

  • Perinatal bleeding can result in fatal outcomes in about 10% of cases, highlighting the seriousness of the condition.
  • A 29-year-old woman successfully received recombinant activated factor VII during surgery to control severe bleeding after a cesarean section and hysterectomy.
  • The use of rFVIIa allowed for rapid control of hemorrhage, enabling safe identification of the source of bleeding without significant clotting issues post-surgery, suggesting its effectiveness in treating life-threatening obstetrical hemorrhages.

Article Abstract

Perinatal bleeding may lead to a fatal outcome in about 10% of cases. We present a case of a 29 year old woman in childbirth, in whom a preparation of recombinant activated factor VII (rFVIIa, NovoSeven, Novo Nordisk A/S, Bagsvaerd, Denmark) was used with success to control intraoperative bleeding during haemorrhagic shock after caesarean section and obstetrical hysterectomy, in the course of the patient's third abdominal cavity revision for continuing blood loss. Administration of the preparation enabled for quick intraoperative control of haemorrhage, which allowed safe and clear identification and elimination of the cause of bleeding. No significant clotting abnormalities were noted at postoperative monitoring of the coagulation system. rFVIIa seems to be an effective alternative treatment of life-threatening haemorrhages in obstetrics, allowing for quick arrest of bleeding, and thus safe control of intraoperative local hemostasis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

recombinant activated
8
activated factor
8
factor vii
8
vii rfviia
8
rfviia novoseven
8
haemorrhagic shock
8
control intraoperative
8
[effect recombinant
4
novoseven patient
4
patient haemorrhagic
4

Similar Publications

Purpose Of Review: This review aims to examine recent advances in the understanding of injury-induced endotheliopathy and therapeutics to mitigate its development in critically injured patients.

Recent Findings: Clinical studies have clearly demonstrated that syndecan-1 ectodomains can be found in circulation after various types of trauma and injury and correlates with worse outcomes. As the mechanisms of endotheliopathy are better understood, pathologic hyperadhesive forms of von Willebrand factor, along with a relative deficiency of its cleaving enzyme, a disintegrin and metalloprotease with thrombospondin type I motifs, member 13 (ADAMTS13), have emerged as additional biomarkers.

View Article and Find Full Text PDF

Combination therapy with checkpoint inhibitors blocks inhibitory immune cell signaling and improves clinical responses to anticancer treatments. However, continued development of innovative and controllable delivery systems for immune-stimulating agents is necessary to optimize clinical responses. Herein, we engineered to deliver recombinant granulocyte macrophage colony stimulating factor (GM-CSF) in a controllable manner for combination treatment with a programmed death-ligand 1 (PD-L1) inhibitor.

View Article and Find Full Text PDF

Assays of Platelet SNARE-actin Interactions.

Methods Mol Biol

January 2025

Division of Hemostasis and Thrombosis, Department of Medicine, BIDMC, Harvard Medical School, Boston, MA, USA.

The actin cytoskeleton serves an important, but poorly characterized, role in controlling granule exocytosis. The dynamic nature of actin remodeling allows it to act both as a barrier to prevent indiscriminate granule release and as a facilitator of membrane fusion. In its capacity to promote exocytosis, filamentous actin binds to components of the exocytotic machinery through actin binding proteins, but also through direct interactions with SNAREs.

View Article and Find Full Text PDF

A set of nCN/WO composites was synthesized through a simple thermal treatment for gold recovery from the simulated effluent of a non-cyanide-based plating bath. The obtained results exhibited that all nCN/WO composites demonstrated a higher photocatalytic activity for gold recovery than their pristine components due to the formation of nanocomposites which paved a convenient pathway for charge transfer. Among all synthesized composites, the 5.

View Article and Find Full Text PDF

Ischemic stroke results in significant long-term disability and mortality worldwide. Although existing therapies, such as recombinant tissue plasminogen activator and mechanical thrombectomy, have shown promise, their application is limited by stringent conditions. Mesenchymal stem cell (MSC) transplantation, especially using SB623 cells (modified human bone marrow-derived MSCs), has emerged as a promising alternative, promoting neurogenesis and recovery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!